Boehringer Ingelheim Received Praise from Australia's Best and Featured in the Leading Business-to-Business Magazine

Share Article

Australia's Best Magazine, published by Bean Media Group in Sydney, are very picky when they select companies for editorials within their publications, however, Boehringer Ingelheim seems to have hit the mark and was chosen for an exclusive feature in September's edition of Australia's Best

Australia's Best Magazine, published by Bean Media Group in Sydney, are very picky when they select companies for editorials within their publications, however, Boehringer Ingelheim seems to have hit the mark and was chosen for an exclusive feature in September's edition of Australia's Best. Boehringer Ingelheim is a research driven group of companies dedicated to the research, development, manufacture and marketing of pharmaceuticals that improve health and the quality of life.

Boehringer Ingelheim's business consists of Human Pharmaceuticals and Animal Health with a focus on innovative drugs and treatments that represent major therapeutic advances. Boehringer Ingelheim's products have long been highly successful in the treatment of central nervous system, respiratory, cardiovascular, urological and virological disorders.

The company has research and development facilities in ten countries and production plants in more than 20 countries. They are one of the Top 20 pharmaceutical companies worldwide, with approximately 39, 800 employees in 135 affiliated companies and 47 countries worldwide.

With its headquarters at Ingelheim, the German town where the family-owned company was founded in 1885, Boehringer Ingelheim has become the largest independent pharmaceutical company in the world.

The entire editorial feature, together with supplier advertisements, that was published in the award-winning publication can be downloaded here.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

CHRIS DUTTON
Visit website